214 citations
,
March 1993 in “Archives of Dermatology” Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.
18 citations
,
March 2016 in “Cosmetics” Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.
September 2024 in “Journal of the American Academy of Dermatology” Telogen effluvium in kids is often caused by illness or poor nutrition, especially in girls.
Telogen effluvium is a hair loss condition that can be treated with medications like minoxidil.
March 2003 in “CRC Press eBooks” Telogen effluvium is hair loss caused by many hairs stopping growth suddenly, often due to stress or illness, but sometimes it's normal and not due to disease.
August 2019 in “DOAJ (DOAJ: Directory of Open Access Journals)” Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.
67 citations
,
January 2013 in “Indian Journal of Dermatology, Venereology and Leprology” Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.
1 citations
,
April 2024 in “Piel” Telogen effluvium causes sudden hair loss, often due to stress or changes, and is treated by addressing the cause and offering support.
A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.
16 citations
,
February 2001 in “PubMed” Allergic scalp reactions can cause temporary hair loss.
40 citations
,
May 2020 in “Cureus” The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.
July 1998 in “Chromatographia” Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.
March 2023 in “International Journal of Biomedicine” Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.
July 2024 in “Medical alphabet” Modern therapies, like fractional laser, effectively treat telogen effluvium.
January 2022 in “Journal of Drug Delivery and Therapeutics” COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
58 citations
,
November 2020 in “International Journal of Dermatology” COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.
October 2011 in “American Academy of Pediatrics eBooks” The document did not provide specific information on Telogen Effluvium.
70 citations
,
January 2015 in “Journal of Clinical and Diagnostic Research” Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.
2 citations
,
December 2021 in “Dermatology Online Journal” COVID-19 has increased hair loss, but many patients see regrowth within months.
May 2022 in “Acta Scientific Women's Health” A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.
May 2022 in “Authorea (Authorea)” A 17-year-old girl has had repeated hair loss since childhood, which can be triggered by infections like COVID-19.
April 2024 in “Dermatovenerologiâ, kosmetologiâ” Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.
January 2018 in “Springer eBooks” Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.
5 citations
,
June 2019 in “JAAD Case Reports” Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.
September 2024 in “JAAD International” Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.
January 2020 in “Hair therapy & transplantation” Telogen effluvium is a common hair loss where hair sheds due to stress but new hair still grows.
January 2011 in “Medicina interna de México” The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.
7 citations
,
December 2021 in “Journal of The American Academy of Dermatology” COVID-19 can cause hair loss starting as early as 18 days after infection.
10 citations
,
August 2021 in “Journal of Cosmetic Dermatology” Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.
August 2024 in “International Journal of Health Science” Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.